Ye Cui1, Sevgi Keles2, Louis-Marie Charbonnier1, Amélie M Julé1, Lauren Henderson1, Seyma Celikbilek Celik2, Ismail Reisli2, Chen Shen3, Wen Jun Xie4, Klaus Schmitz-Abe5, Hao Wu6, Talal A Chatila7. 1. Division of Immunology, Boston Children's Hospital, and the Department of Pediatrics, Harvard Medical School, Boston, Mass. 2. Necmettin Erbakan University, Meram Medical Faculty, Division of Pediatric Allergy and Immunology, Konya, Turkey. 3. Program in Molecular and Cellular Medicine, Department of Pediatrics, Boston Children's Hospital, Harvard Medical School, Boston, Mass; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Mass. 4. Department of Chemistry, Massachusetts Institute of Technology, Cambridge, Mass. 5. Division of Newborn Medicine and Neonatal Genomics Program, Boston Children's Hospital, Harvard Medical School, Boston, Mass. 6. Division of Immunology, Boston Children's Hospital, and the Department of Pediatrics, Harvard Medical School, Boston, Mass; Program in Molecular and Cellular Medicine, Department of Pediatrics, Boston Children's Hospital, Harvard Medical School, Boston, Mass. 7. Division of Immunology, Boston Children's Hospital, and the Department of Pediatrics, Harvard Medical School, Boston, Mass. Electronic address: talal.chatila@childrens.harvard.edu.
Abstract
BACKGROUND: Mutations affecting DNA polymerases have been implicated in genomic instability and cancer development, but the mechanisms by which they can affect the immune system remain largely unexplored. OBJECTIVE: We sought to establish the role of DNA polymerase δ1 catalytic subunit (POLD1) as the cause of a primary immunodeficiency in an extended kindred. METHODS: We performed whole-exome and targeted gene sequencing, lymphocyte characterization, molecular and functional analyses of the DNA polymerase δ (Polδ) complex, and T- and B-cell antigen receptor repertoire analysis. RESULTS: We identified a missense mutation (c. 3178C>T; p.R1060C) in POLD1 in 3 related subjects who presented with recurrent, especially herpetic, infections and T-cell lymphopenia with impaired T-cell but not B-cell proliferation. The mutation destabilizes the Polδ complex, leading to ineffective recruitment of replication factor C to initiate DNA replication. Molecular dynamics simulation revealed that the R1060C mutation disrupts the intramolecular interaction between the POLD1 CysB motif and the catalytic domain and also between POLD1 and the Polδ subunit POLD2. The patients exhibited decreased numbers of naive CD4 and especially CD8 T cells in favor of effector memory subpopulations. This skewing was associated with oligoclonality and restricted T-cell receptor β-chain V-J pairing in CD8+ but not CD4+ T cells, suggesting that POLD1R1060C differentially affects peripheral CD8+ T-cell expansion and possibly thymic selection. CONCLUSION: These results identify gene defects in POLD1 as a novel cause of T-cell immunodeficiency.
BACKGROUND: Mutations affecting DNA polymerases have been implicated in genomic instability and cancer development, but the mechanisms by which they can affect the immune system remain largely unexplored. OBJECTIVE: We sought to establish the role of DNA polymerase δ1 catalytic subunit (POLD1) as the cause of a primary immunodeficiency in an extended kindred. METHODS: We performed whole-exome and targeted gene sequencing, lymphocyte characterization, molecular and functional analyses of the DNA polymerase δ (Polδ) complex, and T- and B-cell antigen receptor repertoire analysis. RESULTS: We identified a missense mutation (c. 3178C>T; p.R1060C) in POLD1 in 3 related subjects who presented with recurrent, especially herpetic, infections and T-cell lymphopenia with impaired T-cell but not B-cell proliferation. The mutation destabilizes the Polδ complex, leading to ineffective recruitment of replication factor C to initiate DNA replication. Molecular dynamics simulation revealed that the R1060C mutation disrupts the intramolecular interaction between the POLD1 CysB motif and the catalytic domain and also between POLD1 and the Polδ subunit POLD2. The patients exhibited decreased numbers of naive CD4 and especially CD8 T cells in favor of effector memory subpopulations. This skewing was associated with oligoclonality and restricted T-cell receptor β-chain V-J pairing in CD8+ but not CD4+ T cells, suggesting that POLD1R1060C differentially affects peripheral CD8+ T-cell expansion and possibly thymic selection. CONCLUSION: These results identify gene defects in POLD1 as a novel cause of T-cell immunodeficiency.
Authors: Harlan S Robins; Paulo V Campregher; Santosh K Srivastava; Abigail Wacher; Cameron J Turtle; Orsalem Kahsai; Stanley R Riddell; Edus H Warren; Christopher S Carlson Journal: Blood Date: 2009-08-25 Impact factor: 22.113
Authors: Fadwa A Elsayed; Carli M J Tops; Maartje Nielsen; Dina Ruano; Hans F A Vasen; Hans Morreau; Frederik J Hes; Tom van Wezel Journal: Mol Genet Genomic Med Date: 2019-03-02 Impact factor: 2.183
Authors: David N Church; Sarah E W Briggs; Claire Palles; Enric Domingo; Stephen J Kearsey; Jonathon M Grimes; Maggie Gorman; Lynn Martin; Kimberley M Howarth; Shirley V Hodgson; Kulvinder Kaur; Jenny Taylor; Ian P M Tomlinson Journal: Hum Mol Genet Date: 2013-03-24 Impact factor: 6.150
Authors: Diana X Nichols-Vinueza; Ottavia M Delmonte; Vanessa Bundy; Marita Bosticardo; Michael T Zimmermann; Nikita R Dsouza; Francesca Pala; Kerry Dobbs; Jennifer Stoddard; Julie E Niemela; Hye Sun Kuehn; Michael D Keller; Cesar M Rueda; Roshini S Abraham; Raul Urrutia; Sergio D Rosenzweig; Luigi D Notarangelo Journal: J Clin Immunol Date: 2020-11-02 Impact factor: 8.317